系统中的差距:支持患有痴呆症的人
Madeline King1, Allie Peckham1,2,3, Husayn Marani1,4
1North American Observatory on Health Systems and Policies, Toronto, Ontario, Canada.
Journal of aging & social policy
|July 3, 2023
概括
痴呆症护理计划面临的挑战是由于系统缺陷,满足各种需求. 改善基础设施和了解痴呆症对于支持患有痴呆症的个人及其照顾者至关重要.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 痴呆症患者及其照顾者在获得足够的支持服务方面面临重大挑战.
- 现有的痴呆症护理计划往往无法满足这一群体复杂而多样化的需求.
研究的目的:
- 探索项目管理人员,痴呆症患者,无薪护理人员和关于痴呆症护理计划的决策者的看法.
- 评估当前的痴呆症护理计划是否充分满足痴呆症患者及其照顾者的需求.
主要方法:
- 在2018年至2020年期间,在五个北美司法管辖区进行了40次半结构面试.
- 从包括服务提供商,接收者和决策者在内的各种利益相关方收集了见解.
主要成果:
- 发现了三个关键缺口:系统基础设施断开,综合服务不足,对痴呆症的理解不一致.
- 尽管计划实施,但显著的系统限制阻碍了对痴呆症患者及其照顾者的充分支持.
结论:
- 目前的痴呆症护理系统需要大幅度改进,以有效地满足痴呆症患者的需求.
- 解决基础设施,服务全面性和对痴呆症的共享理解对于改善护理至关重要.
- 系统性变化是必要的,以确保痴呆症护理计划充分支持个人及其照顾者.
相关概念视频
Dementia
141
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
141
Alzheimer's Disease: Overview
527
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
527
Alzheimer's Disease: Treatment
220
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
220
Intellectual Disability
120
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
120
Cognitive Development During Adulthood
160
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
160
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K


